课题基金 / 基金详情

Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes

Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes
使用 D-环丝氨酸进行认知修复以改善戒烟结果
批准号:
8144483
负责人:
A EDEN EVINS
金额:
$19.02万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2013-05-31

项目摘要

项目成果

A EDEN EVINS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT One in five Americans smoke tobacco. Each year over 440,000 people in the US and 5 million worldwide die from smoking-related illness, and the global mortality toll is rising. Pharmacotherapy for smoking cessation is highly cost effective, but relapse rates are high, and fewer than 20% who attempt cessation are successful on a given attempt. After completion of smoking cessation treatment, recently abstinent smokers face repeated environmental cues that often trigger relapse. Cue exposure therapies are directed at reducing cravings in response to such cues, but these strategies have had only limited efficacy to date. Now, a novel strategy for strengthening the efficacy of cue exposure approaches is at hand. Basic research has identified d-cycloserine (DCS), a partial agonist of the NMDA receptor, as an agent capable of enhancing extinction learning. Following success in animal models, DCS was first applied to the enhancement of extinction learning for the treatment of acrophobia. Ongoing study has further supported the efficacy of single-dose applications of DCS to enhance the efficacy of exposure based treatments across the anxiety disorders, presumably by enhancing the memory of successful exposure sessions. There is also encouraging evidence for the similar segmentation of extinction based learning in cue exposure models of drug addiction. In this application, we propose to study DCS enhancement for cue exposure as applied as a relapse prevention strategy for smoking cessation. Specifically, we propose to assess the effects of two sessions of single dose DCS combined with cue-exposure treatment (CET) conducted one week apart in a randomized, double-blind, placebo-controlled, parallel group design trial. This treatment will be offered as a relapse-prevention strategy for smokers who are abstinent upon completing a standard open label 7-week smoking cessation treatment offered in our center. Outcomes will be acute changes in cue-reactivity and craving at a Post-Extinction Assessment conducted 2 days after the second CET session and maintenance of abstinence over a 6-week follow-up period. Accordingly, the proposed study has the potential of supporting for a novel cognitive remediation strategy to enhance the efficacy of cue exposure treatments for the maintenance of smoking cessation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
  • 批准号:
    10641911
  • 项目类别:
  • 资助金额:
    $81.35万
  • 财政年份:
    2021
  • 负责人:
    A EDEN EVINS
  • 依托单位:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
  • 批准号:
    10211907
  • 项目类别:
  • 资助金额:
    $78.52万
  • 财政年份:
    2021
  • 负责人:
    A EDEN EVINS
  • 依托单位:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
  • 批准号:
    10689064
  • 项目类别:
  • 资助金额:
    $66.48万
  • 财政年份:
    2021
  • 负责人:
    A EDEN EVINS
  • 依托单位:
海外基金